{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:01:08Z","timestamp":1792195268440,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ebiom.2022.104186","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T06:33:03Z","timestamp":1658730783000},"page":"104186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies"],"prefix":"10.1016","volume":"82","author":[{"given":"Supriya","family":"Ravichandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-7965","authenticated-orcid":false,"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ebiom.2022.104186_bib0001","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/v11080678","article-title":"Evaluation of diagnostic performance of three indirect enzyme-linked immunosorbent assays for the detection of IgG antibodies to Ebola virus in human sera","volume":"11","author":"Paweska","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104186_bib0002","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JCM.01979-16","article-title":"Development of a sensitive and specific serological assay based on luminex technology for detection of antibodies to Zaire Ebola virus","volume":"55","author":"Ayouba","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104186_bib0003","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/CMR.00003-16","article-title":"Diagnosis of Ebola virus disease: past, present, and future","volume":"29","author":"Broadhurst","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ebiom.2022.104186_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00675-7","article-title":"Field performance of three Ebola rapid diagnostic tests used during the 2018-20 outbreak in the eastern Democratic Republic of the Congo: a retrospective, multicentre observational study","author":"Mukadi-Bamuleka","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104186_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001980","article-title":"Performance of the GeneXpert Ebola assay for diagnosis of Ebola virus disease in Sierra Leone: a field evaluation study","volume":"13","author":"Semper","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104186_bib0006","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.4102\/ajlm.v10i1.1414","article-title":"The deployment of mobile diagnostic laboratories for Ebola virus disease diagnostics in Sierra Leone and Guinea","volume":"10","author":"Presser","year":"2021","journal-title":"Afr J Lab Med"},{"issue":"suppl 3","key":"10.1016\/j.ebiom.2022.104186_bib0007","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1093\/infdis\/jiw296","article-title":"Ebola virus disease diagnostics, Sierra Leone: analysis of real-time reverse transcription-polymerase chain reaction values for clinical blood and oral swab specimens","volume":"214","author":"Erickson","year":"2016","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104186_bib0008","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.chom.2020.01.001","article-title":"Longitudinal human antibody repertoire against complete viral proteome from Ebola virus survivor reveals protective sites for vaccine design","volume":"27","author":"Khurana","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"suppl 1","key":"10.1016\/j.ebiom.2022.104186_bib0009","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit","volume":"179","author":"Rowe","year":"1999","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.ebiom.2022.104186_bib0010","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.vaccine.2020.02.044","article-title":"Prior vaccination with recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection","volume":"38","author":"Kasereka","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104186_bib0011","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJMc2113505","article-title":"Antibody use during an outbreak of Ebola virus disease in the Democratic Republic of Congo, 2020","volume":"386","author":"Mulangu","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ebiom.2022.104186_bib0012","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa2024670","article-title":"Ebola virus transmission initiated by relapse of systemic Ebola virus disease","volume":"384","author":"Mbala-Kingebeni","year":"2021","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.ebiom.2022.104186_bib0013","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104186_bib0014","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1286-4579(03)00051-0","article-title":"Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins","volume":"5","author":"Groen","year":"2003","journal-title":"Microbes Infect"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104186_bib0015","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.vaccine.2014.10.040","article-title":"HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians","volume":"33","author":"Voronin","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104186_bib0016","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/JCM.01573-09","article-title":"HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection","volume":"48","author":"Khurana","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104186_bib0017","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1128\/JVI.80.5.2092-2099.2006","article-title":"Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies","volume":"80","author":"Khurana","year":"2006","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104186_bib0018","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.926","article-title":"Vaccine-induced HIV seropositivity\/reactivity in noninfected HIV vaccine recipients","volume":"304","author":"Cooper","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104186_bib0019","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.vaccine.2016.11.083","article-title":"Comparison of platform technologies for assaying antibody to Ebola virus","volume":"35","author":"Wilkinson","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104186_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100920","article-title":"Human antibody repertoire following Ebola virus infection and vaccination","volume":"23","author":"Fuentes","year":"2020","journal-title":"iScience"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104186_bib0021","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.4201","article-title":"Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies","volume":"22","author":"Khurana","year":"2016","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104186_bib0022","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1128\/JVI.07085-11","article-title":"Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in young adults and children","volume":"86","author":"Verma","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2022.104186_bib0023","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ebiom.2019.09.055","article-title":"Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge","volume":"49","author":"Marzi","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104186_bib0024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104186_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00193395","article-title":"Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?","volume":"181","author":"Becker","year":"1992","journal-title":"Med Microbiol Immunol"},{"issue":"3-4","key":"10.1016\/j.ebiom.2022.104186_bib0026","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF01313780","article-title":"Ebola protein analyses for the determination of genetic organization","volume":"133","author":"Elliott","year":"1993","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104186_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0166-0934(03)00131-9","article-title":"Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus","volume":"111","author":"Lucht","year":"2003","journal-title":"J Virol Methods"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104186_bib0028","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1128\/JCM.39.9.3267-3271.2001","article-title":"Detection of Ebola viral antigen by enzyme-linked immunosorbent assay using a novel monoclonal antibody to nucleoprotein","volume":"39","author":"Niikura","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104186_bib0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/acsnano.7b07021","article-title":"A serological point-of-care test for the detection of IgG antibodies against Ebola virus in human survivors","volume":"12","author":"Brangel","year":"2018","journal-title":"ACS Nano"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642200367X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642200367X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:20:29Z","timestamp":1762456829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642200367X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":29,"alternative-id":["S235239642200367X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104186","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ebola-Detect: A differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104186"}}